Triazolam: Triazolam is an extremely potent, ultra-short-acting benzodiazepine prescribed for short-term treatment of insomnia (7-10 days maximum). It was withdrawn from the UK market due to high incidence of psychiatric adverse reactions including amnesia, confusion, paradoxical agitation, and hall
Related pages